Enzymatic Antibody Tagging: Toward a Universal Biocompatible Targeting Tool

Trends in Cardiovascular Medicine

Volumn 22, Issue 4, 2012, Pages 105-111

  Ta, Hang T ^a   Peter, Karlheinz ^a   Hagemeyer, Christoph E ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BRENTUXIMAB VEDOTIN; NANOPARTICLE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SORTASE; TRASTUZUMAB EMTANSINE;

BIOCOMPATIBILITY; BIOTECHNOLOGY; BREAST CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PROCEDURE; CELL HOMING; CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; LYMPHOMA; MOLECULAR IMAGING; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS;

AMINOACYLTRANSFERASES; BACTERIAL PROTEINS; CARDIOVASCULAR DISEASES; CYSTEINE ENDOPEPTIDASES; DRUG DELIVERY SYSTEMS; IMMUNOENZYME TECHNIQUES;

EID: 84866928403     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.07.004     Document Type: Review

References (64)

1. Barat B., Wu A.M. Metabolic biotinylation of recombinant antibody by biotin ligase retained in the endoplasmic reticulum. Biomol Eng 2007, 24:283-291.
2. Bartelle B.B., Berríos-Otero C.A., Rodriguez J.J., et al. Novel genetic approach for in vivo vascular imaging in mice. Circ Res 2012, 110:938-947.
3. Beckett D., Kovaleva E., Schatz P.J. A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci 1999, 8:921-929.
4. Besheer A., Hertel T.C., Kressler J., et al. Enzymatically catalyzed conjugation of a biodegradable polymer to proteins and small molecules using microbial transglutaminase. Methods Mol Biol 2011, 751:17-27.
5. Chen I., Dorr B.M., Liu D.R. A general strategy for the evolution of bond-forming enzymes using yeast display. Proc Natl Acad Sci U S A 2011, 108:11399-11404.
6. Chen I., Howarth M., Lin W., Ting A.Y. Site-specific labeling of cell surface proteins with biophysical probes using biotin ligase. Nat Methods 2005, 2:99-104.
7. Choi-Rhee E., Schulman H., Cronan J.E. Promiscuous protein biotinylation by Escherichia coli biotin protein ligase. Protein Sci 2004, 13:3043-3050.
8. Clow F., Fraser J.D., Proft T. Immobilization of proteins to biacore sensor chips using Staphylococcus aureus sortase A. Biotechnol Lett 2008, 30:1603-1607.
9. de Boer E., Rodriguez P., Bonte E., et al. Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A 2003, 100:7480-7485.
10. Doronina S.O., Toki B.E., Torgov M.Y., et al. Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Nat Biotechnol 2003, 21:778-784.
11. Eisenhardt S.U., Schwarz M., Bassler N., Peter K. Subtractive single-chain antibody (scFv) phage-display: Tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Nat Protoc 2007, 2:3063-3073.
12. Eisenhardt S.U., Schwarz M., Schallner N., et al. Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 2007, 109:3521-3528.
13. Fontana A., Spolaore B., Mero A., Veronese F.M. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase. Adv Drug Deliv Rev 2008, 60:13-28.
14. Gilmore J.M., Scheck R.A., Esser-Kahn A.P., et al. N-terminal protein modification through a biomimetic transamination reaction. Angew Chem Int Ed 2006, 45:5307-5311.
15. Gualberto A. Brentuximab Vedotin (SGN-35), an antibody-drug conjugate for the treatment of CD30-positive malignancies. Expert Opin Investig Drugs 2012, 21:205-216.
16. Hagemeyer C.E., Schwarz M., Peter K. Single-chain antibodies as new antithrombotic drugs. Semin Thromb Hemost 2007, 33:185-195.
17. Hagemeyer C.E., Tomic I., Jaminet P., et al. Fibrin-targeted direct factor Xa inhibition: Construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide. Thromb Haemost 2004, 92:47-53.
18. Hagemeyer C.E., Tomic I., Weirich U., et al. Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase. J Thromb Haemost 2004, 2:797-803.
19. Hagemeyer C.E., von zur Muhlen C., von Elverfeldt D., Peter K. Single-chain antibodies as diagnostic tools and therapeutic agents. Thromb Haemost 2009, 101:1012-1019.
20. Hermanson G.T. Antibody modification and conjugation. Bioconjugate Techniques 2008, 783-823. Academic Press, Oxford.
21. Howarth M., Takao K., Hayashi Y., Ting A.Y. Targeting quantum dots to surface proteins in living cells with biotin ligase. Proc Natl Acad Sci U S A 2005, 102:7583-7588.
22. Howarth M., Ting A.Y. Imaging proteins in live mammalian cells with biotin ligase and monovalent streptavidin. Nat Protoc 2008, 3:534-545.
23. Hu B.H., Messersmith P.B. Rational design of transglutaminase substrate peptides for rapid enzymatic formation of hydrogels. J Am Chem Soc 2003, 125:14298-14299.
24. Iakovenko A., Rostkova E., Merzlyak E., et al. Semi-synthetic Rab proteins as tools for studying intermolecular interactions. FEBS Lett 2000, 468:155-158.
25. Krop I.E., Beeram M., Modi S., et al. Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancer. J Clin Oncol 2010, 28:2698-2704.
26. Lin C.W., Ting A.Y. Transglutaminase-catalyzed site-specific conjugation of small-molecule probes to proteins in vitro and on the surface of living cells. J Am Chem Soc 2006, 128:4542-4543.
27. Madej M.P., Coia G., Williams C.C., et al. Engineering of an anti-epidermal growth factor receptor antibody to single chain format and labeling by sortase A-mediated protein ligation. Biotechnol Bioeng 2012, 109:1461-1470.
28. Maeda Y., Yoshino T., Takahashi M., et al. Noncovalent immobilization of streptavidin on in vitro- and in vivo-biotinylated bacterial magnetic particles. Appl Environ Microbiol 2008, 74:5139-5145.
29. Manjappa A.S., Chaudhari K.R., Venkataraju M.P., et al. Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor. J Control Release 2011, 150:2-22.
30. Min D.J., Andrade J.D., Stewart R.J. Specific immobilization of in vivo biotinylated bacterial luciferase and FMN:NAD(P)H oxidoreductase. Anal Biochem 1999, 270:133-139.
31. Nesbeth D., Williams S.L., Chan L., et al. Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation. Mol Ther 2006, 13:814-822.
32. Niers J.M., Chen J.W., Weissleder R., Tannous B.A. Enhanced in vivo imaging of metabolically biotinylated cell surface reporters. Anal Chem 2011, 83:994-999.
33. Nyanguile O., Dancik C., Blakemore J., et al. Synthesis of adenoviral targeting molecules by intein-mediated protein ligation. Gene Ther 2003, 10:1362-1369.
34. Parthasarathy R., Subramanian S., Boder E.T. Sortase A as a novel molecular "stapler" for sequence-specific protein conjugation. Bioconjug Chem 2007, 18:469-476.
35. Peter K., Graeber J., Kipriyanov S., et al. Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa. Circulation 2000, 101:1158-1164.
36. Peter K., Gupta A., Nordt T., et al. Construction and in vitro testing of a novel fab-hirudin-based fusion protein that targets fibrin and inhibits thrombin in a factor xa-dependent manner. J Cardiovasc Pharmacol 2000, 42:237-244.
37. Media release: Roche's targeted investigational breast cancer medicine, trastuzumab emtansine (T-DM1), reduced the risk of cancer worsening or death by 35 percent in pivotal phase III trial Roche, Accessed June 18, 2012. http://www.roche.com/media/media_releases/med-cor-2012-06-03b.htm.
38. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 2011, 123:e18-e209.
39. Samantaray S., Marathe U., Dasgupta S., et al. Peptide-sugar ligation catalyzed by transpeptidase sortase: A facile approach to neoglycoconjugate synthesis. J Am Chem Soc 2008, 130:2132-2133.
40. Sato H., Hayashi E., Yamada N., et al. Further studies on the site-specific protein modification by microbial transglutaminase. Bioconjug Chem 2001, 12:701-710.
41. Sato M., Sadamoto R., Niikura K., et al. Site-specific introduction of sialic acid into insulin. Angew Chem Int Ed 2004, 43:1516-1520.
42. Schatz PJ: 1998. Patent title: Biotinylation of proteins. Assignee: Affymax Technologies N.V. Issuing Organization: United States Patent and Trademark Office. Patent No. 5723584.
43. Schmid E.L., Keller T.A., Dienes Z., Vogel H. Reversible oriented surface immobilization of functional proteins on oxide surfaces. Anal Chem 1997, 69:1979-1985.
44. Schwarz M., Meade G., Stoll P., et al. Conformation-specific blockade of the integrin GPIIb/IIIa: A novel antiplatelet strategy that selectively targets activated platelets. Circ Res 2006, 99:25-33.
45. 3 designed by subtractive selection from naïve human phage libraries. FASEB J 2004, 18:1704-1706.
46. Stoll P., Bassler N., Hagemeyer C.E., et al. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation. Arterioscler Thromb Vasc Biol 2007, 27:1206-1212.
47. Strijbis K., Spooner E., Ploegh H.L. Protein ligation in living cells using sortase. Traffic 2012, 13:780-789.
48. Sugimura Y., Ueda H., Maki M., Hitomi K. Novel site-specific immobilization of a functional protein using a preferred substrate sequence for transglutaminase 2. J Biotechnol 2007, 131:121-127.
49. Sung K., Maloney M.T., Yang J., Wu C. A novel method for producing mono-biotinylated, biologically active neurotrophic factors: An essential reagent for single molecule study of axonal transport. J Neurosci Methods 2011, 200:121-128.
50. Ta H.T., Prabhu S., Leitner E., et al. Enzymatic single-chain antibody tagging: A universal approach to targeted molecular imaging and cell homing in cardiovascular disease. Circ Res 2011, 109:365-373.
51. Takazawa T., Kamiya N., Ueda H., Nagamune T. Enzymatic labeling of a single chain variable fragment of an antibody with alkaline phosphatase by microbial transglutaminase. Biotechnol Bioeng 2004, 86:399-404.
52. Taki M., Shiota M., Taira K. Transglutaminase-mediated N- and C-terminal fluorescein labeling of a protein can support the native activity of the modified protein. Protein Eng Des Sel 2004, 17:119-126.
53. Tam J., Xu J., Eom K. Methods and strategies of peptide ligation. Biopolymers 2001, 60:194-205.
54. Tanaka T., Kamiya N., Nagamune T. N-terminal glycine-specific protein conjugation catalyzed by microbial transglutaminase. FEBS Lett 2005, 579:2092-2096.
55. Tanaka T., Yamamoto T., Tsukiji S., Nagamune T. Site-specific protein modification on living cells catalyzed by Sortase. Chembiochem 2008, 9:802-807.
56. Tannous B.A., Grimm J., Perry K.F., et al. Metabolic biotinylation of cell surface receptors for in vivo imaging. Nat Methods 2006, 3:391-396.
57. Ton-That H., Liu G., Mazmanian S.K., et al. Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif. Proc Natl Acad Sci U S A 1999, 96:12424-12429.
58. Topcic D., Kim W., Holien J.K., et al. An activation-specific platelet inhibitor that can be turned on/off by medically used hypothermia. Arterioscler Thromb Vasc Biol 2011, 31:2015-2023.
59. von zur Muhlen C., Peter K., Ali Z.A., et al. Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa. J Vasc Res 2008, 46:6-14.
60. von zur Muhlen C., Sibson N.R., Peter K., et al. A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. J Clin Invest 2008, 118:1198-1207.
61. Wang L., Schultz P.G. Expanding the genetic code. Angew Chem Int Ed 2004, 44:34-66.
62. Wang X., Hagemeyer C.E., Hohmann J.D., et al. Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: Validation of a unique non-invasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice. Circulation 2012, 125:3117-3126.
63. Wu P., Shui W., Carlson B.L., et al. Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag. Proc Natl Acad Sci U S A 2009, 106:3000-3005.
64. Wu S., Proft T. The use of sortase-mediated ligation for the immobilisation of bacterial adhesins onto fluorescence-labelled microspheres: A novel approach to analyse bacterial adhesion to host cells. Biotechnol Lett 2010, 32:1713-1718.